Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients ...

Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of cancer cells ...

AT SABCS 2025, researchers presented surgical outcomes for patients who received 6 months of neoadjuvant endocrine therapy for ER-positive, HER2-negative breast cancer.

Is omission of the sentinel lymph node biopsy safe in early breast cancer in patients treated with breast conserving therapy ...

In 2021, Massey also became the first in the state of Virginia to use an FDA-approved substance that allows surgeons to spare the lymph nodes in the vast majority of early-stage breast cancer patients ...

Crucially, the analysis demonstrated that less invasive procedures like TAD/SLNB/TLNB are noninferior to ALND in terms of axillary recurrence based on the lower bound of a 90% confidence interval ...

Preoperative radiation improved T-cell infiltration among patients with hormone receptor-positive, HER2-negative breast ...

Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, ...

Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, ...

Study results show a new technique that analyzes genomic information from a type of skin cancer tumor could help melanoma ...

SLNB can be safely omitted for patients with early-stage breast cancer patients who previously received breast-conserving surgery and whole-breast irradiation.